ArticleSmall (Weinheim an der Bergstrasse, Germany)2026
Reduction-Controlled Tunable Synthesis of Covellite (CuS) Nanoparticles from Water-Soluble Single-Source Precursors.
Article in Small (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
The single source precursor (SSP) approach has been extensively used in preparing technologically important covellite (CuS) nanoparticles (NPs) for its high atom-efficiency and facile control over NPs. However, current SSPs often require time-consuming decomposition in organic solvents at temperatures typically above 100°C. Here, we propose amino acid-derived copper(II)-dithiocarbamate (DTC) complexes, as water-soluble SSPs for low-temperature hydrothermal decomposition. We demonstrate that Cu(II)-DTCs follow a reduction-mediated molecular decomposition pathway to CuS, with the Cu(I) intermediates, Cu(I)-DTCs, isolated and confirmed via formation of crystallographically-characterized phosphine adducts. The Cu(II)-Cu(I) reduction occurs via the intramolecular ligand-to-metal charge-transfer (LMCT), which proves rate-limiting in the decomposition and sensitive to changes in pH and ligand metalation. Tuning the rate of intramolecular LMCT and concomitant formation of Cu(I)-DTC species by varying pH and metalation, monitored by UV-vis spectroscopy, allows the formation rate of molecular building blocks to be controlled, in turn controlling nucleation and growth of NPs. Thus, the same copper-ligand combinations can be utilized to generate a wide range of size-shape tunable CuS NPs (ca. 10-150 nm) cost-effectively and sustainably. These results not only highlight the synthetic utility of this approach but also provide mechanistic insights into the poorly defined molecules-to-materials transformation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.